Original Research

Published on 03 Feb 2021

Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer

in Cancer Immunity and Immunotherapy

Dandan Bao
Chenghao Zhang
Longlong Li
Haihong Wang
Qiuyan Li
Leilei Ni
Yinfeng Lin
Rong Huang
Zhangwei Yang
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.553297

6,055 views
20 citations

Case Report

Published on 02 Feb 2021

Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis

in Cancer Immunity and Immunotherapy

Zizhong Yang
Guoqing Zhang
Qiong Sun
Minglu Liu
Jiakang Shao
Shunchang Jiao

Frontiers in Oncology

doi 10.3389/fonc.2020.611810

4,310 views
2 citations

Original Research

Published on 02 Feb 2021

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis

in Cancer Immunity and Immunotherapy

Amina Ghouzlani
Soumaya Rafii
Mehdi Karkouri
Abdelhakim Lakhdar
Abdallah Badou

Frontiers in Oncology

doi 10.3389/fonc.2020.608609

5,821 views
23 citations

Opinion

Published on 01 Feb 2021

COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy

in Cancer Immunity and Immunotherapy

Karim Hussien El-Shakankery
Joanna Kefas
Rowan Miller

Frontiers in Oncology

doi 10.3389/fonc.2020.631611

3,260 views
2 citations

Original Research

Published on 28 Jan 2021

Pan-Cancer Molecular Characterization of m6A Regulators and Immunogenomic Perspective on the Tumor Microenvironment

in Cancer Immunity and Immunotherapy

Jie Zhu
Jiani Xiao
Min Wang
Daixing Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.618374

9,539 views
32 citations

Original Research

Published on 20 Jan 2021

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment

in Cancer Immunity and Immunotherapy

Yanbin Zhao
Minghui Zhang
Haihong Pu
Shengyue Guo
Shuai Zhang
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.585961

14,487 views
34 citations

Original Research

Published on 19 Jan 2021

Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients

in Cancer Immunity and Immunotherapy

Arutha Kulasinghe
Touraj Taheri
Ken O’Byrne
Brett G. M. Hughes
Liz Kenny
Chamindie Punyadeera

Frontiers in Oncology

doi 10.3389/fonc.2020.607349

13,425 views
31 citations

Original Research

Published on 15 Jan 2021

Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors

in Cancer Immunity and Immunotherapy

Lynn M. Rose
Hannah A. DeBerg
Prakash Vishnu
Jason K. Frankel
Adarsh B. Manjunath
John Paul E. Flores
David M. Aboulafia

Frontiers in Oncology

doi 10.3389/fonc.2020.570752

4,011 views
24 citations

Original Research

Published on 12 Jan 2021

PD-1 Blockade Aggravates Epstein–Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations

in Cancer Immunity and Immunotherapy

Valery Volk
Sebastian J. Theobald
Simon Danisch
Sahamoddin Khailaie
Maja Kalbarczyk
Andreas Schneider
Julia Bialek-Waldmann
Nicole Krönke
Yun Deng
Britta Eiz-Vesper

Frontiers in Oncology

doi 10.3389/fonc.2020.614876

9,507 views
20 citations

Original Research

Published on 11 Jan 2021

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer

in Cancer Immunity and Immunotherapy

Xi Cao
Xinyu Ren
Yidong Zhou
Feng Mao
Yan Lin
Huanwen Wu
Qiang Sun

Frontiers in Oncology

doi 10.3389/fonc.2020.583966

5,514 views
34 citations

Case Report

Published on 11 Jan 2021

Case Report: Significant Response to the Combination of Lenvatinib and Immune Checkpoint Inhibitor in a Patient With Heavily Pretreated Metastatic Triple Negative Breast Cancer

in Cancer Immunity and Immunotherapy

Jin Sun Lee
Susan E. Yost
Yuan Yuan

Frontiers in Oncology

doi 10.3389/fonc.2020.582185

3,900 views
5 citations

Original Research

Published on 06 Jan 2021

Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes

in Cancer Immunity and Immunotherapy

Rong Liu
Ya-Zhou Liao
Wei Zhang
Hong-Hao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2020.575264

5,275 views
17 citations

Original Research

Published on 06 Jan 2021

Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors

in Cancer Immunity and Immunotherapy

Jiaqiao Fan
Jugal Kishore Das
Xiaofang Xiong
Hailong Chen
Jianxun Song

Frontiers in Oncology

doi 10.3389/fonc.2020.574860

12,891 views
14 citations

Original Research

Published on 23 Dec 2020

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment

in Cancer Immunity and Immunotherapy

Wen-Xiu Xu
Jian Zhang
Yu-Ting Hua
Su-Jin Yang
Dan-Dan Wang
Jin-Hai Tang

Frontiers in Oncology

doi 10.3389/fonc.2020.605097

25,856 views
56 citations

Review

Published on 23 Dec 2020

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells

in Cancer Immunity and Immunotherapy

Lu Liu
Lijun Wang
Lihong Zhao
Chen He
Ganlu Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.597468

5,552 views
31 citations

Original Research

Published on 17 Dec 2020

Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer

in Cancer Immunity and Immunotherapy

Shiyong Lin
Qianwen Liu
Jing Wen
Kunhao Bai
Yandong Guo
Jing Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.570128

3,718 views
7 citations

Navigation group

Articles

Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer

Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis

COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy

Pan-Cancer Molecular Characterization of m6A Regulators and Immunogenomic Perspective on the Tumor Microenvironment

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment

Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients

Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors

PD-1 Blockade Aggravates Epstein–Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer

Case Report: Significant Response to the Combination of Lenvatinib and Immune Checkpoint Inhibitor in a Patient With Heavily Pretreated Metastatic Triple Negative Breast Cancer

Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes

Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells

Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer